Sort
10,766 grants matching “checkpoint inhibitor”
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$383,750Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2021 · CA
Targeted Suppression of Cytokine Signaling in the Acute Phase Response
$383,750Jack J Hawiger · Vanderbilt University · R01 · FY2010 · HL
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$383,750Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2020 · CA
Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy
$383,750Taslim A Al-Hilal · University Of Texas El Paso · SC1 · FY2023 · GM
Targeted Suppression of Cytokine Signaling in the Acute Phase Response
$383,750Jack J Hawiger · Vanderbilt University · R01 · FY2008 · HL
Targeted Suppression of Cytokine Signaling in the Acute Phase Response
$383,750Jack J Hawiger · Vanderbilt University · R01 · FY2009 · HL
Targeted Suppression of Cytokine Signaling in the Acute Phase Response
$383,750Jack J Hawiger · Vanderbilt University · R01 · FY2011 · HL
Role of melanoma-PD-1 in cancer progression
$383,636Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2019 · CA
Targeting vulnerabilities of PPM1D-mutant gliomas
$383,426Pratiti Bandopadhayay · Dana-Farber Cancer Inst · R37 · FY2024 · CA
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy
$383,419Aaron Michael Ring · Yale University · P50 · FY2023 · CA
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma
$383,417Qin Yan · Yale University · P50 · FY2023 · CA
Functional Analysis of p53 Polymorphic Variants
$383,402Maureen E Murphy · Wistar Institute · R01 · FY2022 · CA
Conserved Element DNA Vaccine
$383,363Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
$383,350Ryan Bruce Corcoran · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$383,327Benjamin Izar · Columbia University Health Sciences · R37 · FY2024 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$383,285Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
Oncolytic Virotherapy for Multiple Myeloma using VSV
$383,221Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2017 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$383,156Lucia Beatrice Jilaveanu · Yale University · R01 · FY2020 · CA
Uncovering the heterogenous role of senescence in prostate immune suppression and tumorigenesis
$383,156Marcus A. Ruscetti · Univ Of Massachusetts Med Sch Worcester · R37 · FY2024 · CA
Novel Therapeutic Approaches for Aggressive Prostate Cancer
$383,156Arthur M Mercurio · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER
$383,156Qin Yan · Yale University · R01 · FY2021 · CA
Novel Therapeutic Approaches for Aggressive Prostate Cancer
$383,156Arthur M Mercurio · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER
$383,156Qin Yan · Yale University · R01 · FY2019 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$383,156Lucia Beatrice Jilaveanu · Yale University · R01 · FY2018 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$383,156Lucia Beatrice Jilaveanu · Yale University · R01 · FY2021 · CA